Ftse Mib
38.181,57
-0,12%
DAX
22.771,94
0,73%
S&P 500
5.614,56
-2,70%
NASDAQ
17.468,32
-4,00%
Bitcoin
81.115,59
3,35%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Genfit (GNFT) Genfit (GNFT) Notizie

GNFT

Genfit (GNFT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:GNFT
DataOraFonteTitoloSimboloCompagnia
10/03/202522:10GlobeNewswire Inc.Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEsEU:GNFTGenfit
27/02/202522:10GlobeNewswire Inc.GENFIT Announces Revenues and Cash Position as of December 31, 2024EU:GNFTGenfit
21/02/202508:30GlobeNewswire Inc.GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders’ general meetingEU:GNFTGenfit
14/02/202522:10GlobeNewswire Inc.GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs HoldersEU:GNFTGenfit
10/02/202507:30GlobeNewswire Inc.GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs HoldersEU:GNFTGenfit
06/02/202522:10GlobeNewswire Inc.GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025EU:GNFTGenfit
30/01/202508:40GlobeNewswire Inc.GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution PlanEU:GNFTGenfit
29/01/202522:10GlobeNewswire Inc.GENFIT Announces 2025 Financial CalendarEU:GNFTGenfit
13/11/202422:10GlobeNewswire Inc.GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024EU:GNFTGenfit
07/11/202422:10GlobeNewswire Inc.GENFIT Reports Third Quarter 2024 Financial InformationEU:GNFTGenfit
23/09/202407:30GlobeNewswire Inc.GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated ApprovalEU:GNFTGenfit
19/09/202422:10GlobeNewswire Inc.GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate UpdateEU:GNFTGenfit
26/07/202413:45GlobeNewswire Inc.GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary CholangitisEU:GNFTGenfit
17/06/202422:10GlobeNewswire Inc.GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASHEU:GNFTGenfit
17/06/202422:10GlobeNewswire Inc.GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque  EU:GNFTGenfit
10/06/202423:22GlobeNewswire Inc.GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary CholangitisEU:GNFTGenfit
10/06/202423:22GlobeNewswire Inc.GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaineEU:GNFTGenfit
29/05/202422:10GlobeNewswire Inc.GENFIT to Present Latest ACLF Research at EASL Congress™ 2024EU:GNFTGenfit
29/05/202422:10GlobeNewswire Inc.GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024  EU:GNFTGenfit
22/05/202418:05GlobeNewswire Inc.GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024EU:GNFTGenfit
22/05/202418:05GlobeNewswire Inc.GENFIT: May 22, 2024 Combined Shareholders Meeting ResultsEU:GNFTGenfit
14/05/202422:10GlobeNewswire Inc.GENFIT : Information financière du premier trimestre 2024EU:GNFTGenfit
14/05/202422:10GlobeNewswire Inc.GENFIT Reports First Quarter 2024 Financial InformationEU:GNFTGenfit
25/04/202422:10GlobeNewswire Inc.GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)EU:GNFTGenfit
25/04/202422:10GlobeNewswire Inc.GENFIT : Publication du rapport de performance extra-financière 2024 (exercice 2023)EU:GNFTGenfit
15/04/202422:10GlobeNewswire Inc.GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory DocumentsEU:GNFTGenfit
15/04/202422:10GlobeNewswire Inc.GENFIT : Assemblée Générale Mixte du 22 mai 2024 — modalités de mise à disposition des documents préparatoires EU:GNFTGenfit
05/04/202420:00GlobeNewswire Inc.GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-FEU:GNFTGenfit
05/04/202420:00GlobeNewswire Inc.GENFIT : Mise à disposition du Document d’Enregistrement Universel 2023 et du Rapport Annuel Form 20-F 2023EU:GNFTGenfit
04/04/202422:10GlobeNewswire Inc.GENFIT : Résultats financiers annuels 2023 et point sur les activités de la SociétéEU:GNFTGenfit
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:GNFT

La tua Cronologia

TSX
165A
SBI Rheos Hifumi
LSE
0O3Q
Caisse Regionale De Cred...
NASDAQ
KARO
Karooooo
LSE
0JTQ
Lear
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci